Skip to main content
PLOS One logoLink to PLOS One
. 2021 Sep 23;16(9):e0257781. doi: 10.1371/journal.pone.0257781

A diagnostic primer pair to distinguish between wMel and wAlbB Wolbachia infections

Meng-Jia Lau 1,*, Ary A Hoffmann 1, Nancy M Endersby-Harshman 1
Editor: Luciano Andrade Moreira2
PMCID: PMC8459989  PMID: 34555085

Abstract

Detection of the Wolbachia endosymbiont in Aedes aegypti mosquitoes through real-time polymerase chain reaction assays is widely used during and after Wolbachia releases in dengue reduction trials involving the wMel and wAlbB strains. Although several different primer pairs have been applied in current successful Wolbachia releases, they cannot be used in a single assay to distinguish between these strains. Here, we developed a new diagnostic primer pair, wMwA, which can detect the wMel or wAlbB infection in the same assay. We also tested current Wolbachia primers and show that there is variation in their performance when they are used to assess the relative density of Wolbachia. The new wMwA primers provide an accurate and efficient estimate of the presence and density of both Wolbachia infections, with practical implications for Wolbachia estimates in field collected Ae. aegypti where Wolbachia releases have taken place.

Introduction

The bacterium, Wolbachia, is providing an increasingly popular method to inhibit dengue virus transmission in the mosquito, Aedes aegypti. Wolbachia-infected populations involving the wMel strain have now been successfully established in Ae. aegypti in regions including northern Australia, Brazil and Indonesia [13], while wAlbB-infected Ae. aegypti have been established in Malaysia [4]. Detection of the Wolbachia endosymbiont in Ae. aegypti mosquitoes is a standard requirement for good laboratory practice during Wolbachia mosquito releases in dengue reduction programs and for tracking Wolbachia invasions in the field [4, 5]. Real-time polymerase chain reaction (real-time PCR) and High Resolution Melt (HRM) assays (SYBR® equivalent/non-probe) have been developed that enable detection and Wolbachia density estimation for the strain of interest [68]. However, difficulties can arise in using these assays when there is a need to detect Wolbachia and distinguish between multiple Wolbachia strains. In experiments where superinfected lines are used [9], or where mosquitoes carrying different single infections need to be distinguished for experiments or in field collected samples [10], several real-time PCR assays using different primer pairs are currently required. Given that both wMel and wAlbB strains are now actively being used in field releases and that each strain may have advantages in particular situations, the requirement for multiple strain identification is likely to increase in the foreseeable future.

In previous work, we have used a Wolbachia-specific primer pair, w1 [7], which targets a conserved locus VNTR-141 containing tandem repeats [11]. This pair of primers works efficiently in amplifying wMel and wMelPop infections in a real-time PCR and HRM assay, but achieves poor amplification of wAlbB [10]. As well as being used for Wolbachia detection, primers are needed for quantification of Wolbachia density in mosquitoes. There are various Wolbachia specific primers for wMel, wAlbB or wMelPop [9, 1214], but currently there is no standardized assay for Wolbachia screening that is comparable between strains and that can be used to compare results between laboratories. Although cross-laboratory comparability may not be a realistic aim when using a SYBR® equivalent/non-probe-based assay, the use of extra internal controls can make these assays robust for relative density estimates, improving consistency within laboratory experiments [7, 10].

In this study, we developed a diagnostic primer pair that can detect and distinguish between the wMel and wAlbB infections and also provides an estimate of Wolbachia density. In addition, we assessed primer efficiency of some other published primers for Wolbachia in mosquitoes. We also tested quantification cycle (Cq) [15] value differences between primers for different Wolbachia strains to assess primer suitability for relative Wolbachia density estimation.

Materials and methods

Diagnostic primer design

To develop the new primers, we screened for sequence differences between the wMel and wAlbB strains and then focused on the sequences of a DNA-directed RNA polymerase subunit beta/betagene with locus tag WD_RS06155 in wMel and its analogue in wAlbB. We then developed a new pair of primers designated wMwA (Table 1) to distinguish Wolbachia wMel and wAlbB in a single run of a real-time PCR assay, based on two base-pair mismatches at the 3’- end of each primer, which resulted in the Tm peak for wAlbB being separated from that of wMel. We checked the specificity of this primer pair by an initial test of six males and six females for each strain with different Wolbachia infection type (wMel- or wAlbB-infected or uninfected). Subsequent testing was done with female mosquitoes only.

Table 1. Primers for detection of Wolbachia strains and estimation of density.

Primer name Wolbachia status target Targeted locus Forward Reverse Amplicon size (bp) Source
mos uninfected AF154067 AGTTGAACGTATCGTTTCCCGCTAC GAAGTGACGCAGCTTGTGGTCGTCC 77 [7]
aeg uninfected AF154067 ATCAAGAAGCGCCGTGTCG CAGGTGCAGGATCTTCATGTATTCG 66 [7]
w1 wMel VNTR 141 region AAAATCTTTGTGAAGAGGTGATCTGC GCACTGGGATGACAGGAAAAGG 16 [7]
wsp wMel, wAlbB-infected WD_RS04815 GCATTTGGTTAYAAAATGGACGA GGAGTGATAGGCATATCTTCAAT 139 (wMel), 136 (wAlbB) [9]
wMel wMel-infected WD_RS02275 CAAATTGCTCTTGTCCTGTGG GGGTGTTAAGCAGAGTTACGG 68 [9]
wAlbB wAlbB-infected DEJ70_RS01110 CCTTACCTCCTGCACAACAA GGATTGTCCAGTGGCCTTA 109 [9]
wMwA wMel, wAlbB-infected WD_RS06155 GAAGTTGAAGCACAGTGTACCTT GCTTGATATTCCTGTAGATTCATC 155 (both) Newly designed

Sample preparation

The wMel and wAlbB-infected Ae. aegypti were tested for strains transinfected previously [16, 17]. The wMel strain was collected from Cairns, Australia in 2019 from regions that had been invaded several years earlier [2, 12], while the wAlbB strain was derived from a wAlbB infected strain crossed to an Australian background and maintained in the laboratory [13]. An uninfected strain was developed from Ae. aegypti eggs collected in Cairns, Queensland, Australia prior to Wolbachia releases [10, 18].

Female mosquitoes of wMel-infected [17], wAlbB-infected [16] and uninfected were reared with TetraMin® fish food tablets in reverse osmosis (RO) water until the adult stage [19], and then were killed in absolute ethanol before Chelex® DNA extraction. In the standard procedure, DNA of an individual female was extracted in 250 μL 5% Chelex® 100 Resin (Bio-Rad Laboratories, Hercules, CA) and 3 μL of Proteinase K (20 mg/ mL, Bioline Australia Pty Ltd, Alexandria NSW, Australia). The Chelex® 100 Resin solution containing DNA was centrifuged at 12500 rpm for 5 min and DNA solution was pipetted from the supernatant.

LightCycler® efficiency test

After extraction, DNA concentration was measured using a QubitTm 1X dsDNA HS Assay Kit and QubitTm 2.0 fluorometer (ThermoFisher Scientific, Waltham, MA USA), and then diluted ten times before making a three-fold dilution series to test the efficiency of currently-used Wolbachia primers in a real-time PCR assay (Table 1). We also diluted the solution six times before making a three-fold dilution series to investigate the influence of Chelex®-extracted DNA concentration.

For the real-time PCR and HRM, we used a LightCycler® 480 High Resolution Melting Master (HRMM) kit (Roche; Cat. No. 04909631001, Roche Diagnostics Australia Pty. Ltd., Castle Hill New South Wales, Australia) and IMMOLASETM DNA polymerase (5 U/μl) (Bioline; Cat. No. BIO-21047) as described by Lee et al. (2012) (S1 Table). We used 384-well plates with white wells (SSI Bio, Lodi CA USA, Cat. No. 3430–40), and the PCR conditions for DNA amplification beginning with a 10-minute pre-incubation at 95°C (Ramp Rate = 4.8°C/s), followed by 40 cycles of 95°C for 5 seconds (Ramp Rate = 4.8°C/s), 53°C for 15 seconds (Ramp Rate = 2.5°C/s), and 72°C for 30 seconds (Ramp Rate = 4.8°C/s).

Three technical replicates were run for each sample of each dilution and a graph was produced showing the log3 [dilution factor] (x-axis) against mean Cq (y-axis) and a linear trend line (y = mx + c) was fitted. Slope (m) and R2 values were recorded so that PCR amplification efficiency (E) could be evaluated with the equation:

E=(31slope1)×100%

Compare with Chelex® extraction, we also purified DNA from the above Chelex® 100 Resin solution using the PureLinkTM Quick PCR purification Kit (Invitrogen Cat. No. K3100-01), in which the binding buffer B2 was used. In addition, a different DNA extraction method was used: female mosquitoes were homogenized individually in 100 μL STE buffer (10 mM Tris-HCl pH8, 100 mM NaCl, 1mM EDTA), and then incubated at 95°C for 10 minutes. After these extractions, 10 μL supernatant was pipetted into 90 μL ddH2O and made a three-fold dilution series.

Primer quantification cycle comparison and density estimation

Following the efficiency study, we used a mixture of young (4±1days since eclosion) and old (38 ±1days since eclosion) female mosquitoes and tested for Cq value differences between primers for different Wolbachia strains to assess suitability for relative Wolbachia density estimation. A total of 16 Wolbachia-infected mosquito samples were extracted using Chelex® resin and then diluted ten times before real-time PCR.

Results and discussion

Diagnostic primer design

In this study, we developed a diagnostic primer pair, wMwA, that can detect and distinguish between the wMel and wAlbB infections in Aedes aegypti (Fig 1), which is important in simplifying current approaches for Wolbachia identification. In the initial test for the specificity of this primer pair, all uninfected samples were negative, and all Wolbachia-infected samples were positive with distinctive Tm values from Wolbachia wMel (82.6 ± 0.03°C) and wAlbB (80.4 ± 0.02°C) screening (Fig 1C). The high-resolution melt produces two joined peaks when the template contains both Wolbachia wMel and wAlbB DNA (Fig 1D).

Fig 1. Development of primers to detect Wolbachia wMel and wAlbB infection in Aedes aegypti.

Fig 1

(a) The new primer pair wMwA aligns to a region in gene WD_RS06155 of wMel, and also aligns to its analogue in the wAlbB genome which has two base-pair mismatches at the 3’- end; (b) the wMwA primers showed distinct Tm peaks for Wolbachia wMel and wAlbB. (c) the wMwA primers showed distinct Tm values for Wolbachia wMel (82.6 ± 0.03°C) and wAlbB (80.4 ± 0.02°C), the x axis represents the quantification cycle (Cq) and the y axis represents the amplicon melting temperature; (d) the wMwA primers showed two Tm peaks when mixing DNA templates of wMel and wAlbB-infected Ae. aegypti.

Primer efficiency test

We tested the efficiency of each of the primers for screening Wolbachia in Ae. aegypti by using a threefold dilution series. When template DNA was extracted in Chelex® 100 Resin solution, the efficiencies of all primers ranged from 86.4% to 104.9%, (Table 2 and Fig 2) and the efficiency curves all showed an R2 valued greater than 0.99.

Table 2. Primer efficiency for primer pairs used in detection of Wolbachia strains and estimation of density.

Colony Primers Slope of graph R2 Efficiency DNA concentration* (ng/μL) Efficiency curve
Uninfected mos -1.566 0.999 101.659% 5.12 Fig 2A
Uninfected aeg -1.531 0.999 104.946% 5.12 Fig 2B
wMel w1 -1.644 0.999 95.109% 5.24 Fig 2C
wMel wM -1.677 0.998 92.559% 5.24 Fig 2D
wMel wsp -1.767 0.999 86.195% 5.24 Fig 2E
wMel wMwA -1.769 0.999 86.107% 5.24 Fig 2F
wAlbB wA -1.741 0.993 87.953% 6.87 Fig 2G
wAlbB wsp -1.755 0.999 87.032% 6.87 Fig 2H
wAlbB wMwA -1.730 0.997 88.732% 6.87 Fig 2I

*Template DNA was extracted in 250 μL 5% Chelex® 100 Resin and then diluted ten times before making a three-fold dilution series. Concentration was measured before dilution.

Fig 2. Primer efficiency for detection of Wolbachia strains and estimation of density.

Fig 2

DNA was extracted in 250 μL 5% Chelex® 100 Resin and then diluted ten times before making a three-fold dilution series. The primer names are defined in Table 2.

However, we found the amplification curve increase showed inhibition at the first dilution (Fig 3) for each of the primers, particularly when DNA was first diluted six times instead of ten times, resulting in outliers (S1 and S2 Figs and S2 Table). These results highlight a potential risk of lowering the relative density estimate in Wolbachia screening when using a highly concentrated Chelex®-extracted DNA solution. We also found differences between primer efficiency when a different DNA extraction method was used, with changes ranging from -22.2% to 29% (S3 Table). Different DNA extraction methods may affect DNA yield and quality, and/or change PCR inhibitors and their effects, which can increase variation between host and parasite DNA [2022]. It is, therefore, worth noting that new standard curves should be run when changing to a different DNA extraction method, given that the efficiency of primers can deviate substantially from recommendations (90% - 110%) [23, 24] to prevent an inaccurate estimate of relative density being made.

Fig 3. Variation in the shape of the PCR amplification curves.

Fig 3

The curves from left to right represent amplification curves of 1/10, 1/30, 1/90, 1/270 and 1/810 DNA dilution from initial extraction in 250 μL 5% Chelex® 100 Resin. The primers are defined in Table 2.

Cq value comparisons in Chelex® 100 Resin

We noticed that primers had different Cq values even when screening the same individual organism/endosymbiont (Ae. aegypti, wMel or wAlbB) and using the same DNA concentration, despite the efficiency of these primers all falling within 85% - 110%. We therefore tested the Cq ranges of the primers and correlated them with wsp. We found variation between these primers (Fig 2), which would be expected to result in differences in relative density estimates. The relationship between Cq values of different primers all fit into a linear relationship, with R2 greater than 0.97, whereas the coefficient varies from 0.83 to 1.05 (Fig 4). For the newly-designed primer pair wMwA, the coefficients for wMel and wAlbB are similar (0.97 for wMel and 1.04 for wAlbB).

Fig 4. Variation in Cq values when using different Wolbachia primers for the same samples.

Fig 4

Correlation of Cq values between (a) wA and wsp primers in Wolbachia wAlbB screening; (b) wMwA and wsp primers in Wolbachia wAlbB screening; (c) mos and aeg primers in Aedes aegypti screening; (d) wM and wsp primers in Wolbachia wMel screening; (e) wMwA and wsp primers in Wolbachia wMel screening; (f) w1 and wsp primers in Wolbachia wMel screening.

These primer differences could not be explained fully by pipetting error and PCR inhibition [25, 26]. Inhibition effects on DNA amplification can vary when using different primers, and/or when the DNA concentration varies. Intercepts of these Cq values ranged from -1.52 to 1.37 though all primers used in this study only have one copy based on their genomic sequences. However, it is possible that there may be different copies of Wolbachia genes inside mosquito cells [27, 28], such as is documented for the octomom region [29, 30] which can be variable under different environmental conditions [31, 32]. As a result, care is needed when choosing primers for assessing the relative concentration of Wolbachia.

In our study, the wsp primers represent a useful pair of universal primers for amplifying the Wolbachia surface protein gene which has been applied as a Wolbachia diagnostic for decades [14]. Given potential variation between Wolbachia primers, comparisons with universal Wolbachia primers should be undertaken before using the newly-designed primers in Wolbachia density calculations. Our newly-designed primer pair, wMwA, correlated with density estimates based on wsp, with coefficients for both wMel and wAlbB close to 1. Thus, this new primer pair has the potential to be accurate and efficient for large-scale Wolbachia detection and relatively density estimate.

Conclusions

Chelex® DNA extraction and real-time PCR provide an easy and economical approach for detecting both currently-released Wolbachia (wMel and wAlbB) infections in Aedes aegypti, while other options like multiplex probe assays and the use of DNA extraction kits are likely to cost more. Here, we designed a new primer pair, wMwA, which not only identifies wMel and wAlbB at the same time, but is also correlated with density estimates based on a universal Wolbachia primer wsp. We demonstrated this new primer pair has the potential to be accurate and efficient for large-scale Wolbachia detection and relatively density estimates, especially for use in field collected Ae. aegypti.

Supporting information

S1 Table. Real-time PCR reagents and volume in 384-well plates with white wells.

(DOCX)

S2 Table. Primer efficiency when sample DNA was first diluted six times.

(DOCX)

S3 Table. Primer efficiency when sample DNA was extracted using different methods.

(DOCX)

S1 Fig. Primer efficiency when sample DNA was first diluted six times.

DNA is extracted in 250 μL 5% Chelex® 100 Resin and then diluted six times before making a three-fold dilution series. Outliers are marked with red colour and are excluded from the efficiency curve. The primer names are defined in S3 Table.

(PNG)

S2 Fig. Variation in the shape of the PCR amplification curves when sample DNA was first diluted six times.

The curves from left to right represent amplification curves of 1/6, 1/18, 1/54, 1/162 and 1/486 DNA dilution from 250 μL 5% Chelex® 100 Resin. The primers are defined in S2 Table.

(PNG)

Acknowledgments

We thank Perran A. Ross and Jason Axford for providing the mosquito samples. We also thank the support of the Jasper Loftus-Hills award, offered by the Faculty of Science, the University of Melbourne.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

Ary A. Hoffmann is funded by the National Health and Medical Research Council (1132412, 1118640, www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Garcia GdA, Sylvestre G, Aguiar R, da Costa GB, Martins AJ, Lima JBP, et al. Matching the genetics of released and local Aedes aegypti populations is critical to assure Wolbachia invasion. PLoS Negl Trop Dis. 2019;13(1):e0007023. doi: 10.1371/journal.pntd.0007023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Hoffmann AA, Montgomery B, Popovici J, Iturbe-Ormaetxe I, Johnson P, Muzzi F, et al. Successful establishment of Wolbachia in Aedes populations to suppress dengue transmission. Nature. 2011;476(7361):454–7. doi: 10.1038/nature10356 [DOI] [PubMed] [Google Scholar]
  • 3.Tantowijoyo W, Andari B, Arguni E, Budiwati N, Nurhayati I, Fitriana I, et al. Stable establishment of wMel Wolbachia in Aedes aegypti populations in Yogyakarta, Indonesia. PLoS Negl Trop Dis. 2020;14(4):e0008157. Epub 2020/04/18. doi: 10.1371/journal.pntd.0008157; PubMed Central PMCID: PMC7190183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Nazni WA, Hoffmann AA, NoorAfizah A, Cheong YL, Mancini MV, Golding N, et al. Establishment of Wolbachia strain wAlbB in Malaysian populations of Aedes aegypti for dengue control. Curr Biol. 2019;29(24):4241–8. doi: 10.1016/j.cub.2019.11.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Sikulu-Lord MT, Maia MF, Milali MP, Henry M, Mkandawile G, Kho EA, et al. Rapid and non-destructive detection and identification of two strains of Wolbachia in Aedes aegypti by near-infrared spectroscopy. PLoS Negl Trop Dis. 2016;10(6):e0004759. Epub 2016/07/01. doi: 10.1371/journal.pntd.0004759; PubMed Central PMCID: PMC4928868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Simoncini L, Casiraghi M, Bazzocchi C, Sacchi L, Bandi C, Genchi C. Real-time PCR for quantification of the bacterial endosymbionts (Wolbachia) of filarial nematodes. Parassitologia. 2001;43(4):173–8. Epub 2002/10/31. . [PubMed] [Google Scholar]
  • 7.Lee SF, White VL, Weeks AR, Hoffmann AA, Endersby NM. High-throughput PCR assays to monitor Wolbachia infection in the dengue mosquito (Aedes aegypti) and Drosophila simulans. Appl Environ Microbiol. 2012;78(13):4740–3. doi: 10.1128/AEM.00069-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Berticat C, Rousset F, Raymond M, Berthomieu A, Weill M. High Wolbachia density in insecticide-resistant mosquitoes. Proc Biol Sci. 2002;269(1498):1413–6. Epub 2002/06/25. doi: 10.1098/rspb.2002.2022 ; PubMed Central PMCID: PMC1691032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Joubert DA, Walker T, Carrington LB, De Bruyne JT, Kien DHT, Hoang NLT, et al. Establishment of a Wolbachia superinfection in Aedes aegypti mosquitoes as a potential approach for future resistance management. PLoS Pathog. 2016;12(2):e1005434. doi: 10.1371/journal.ppat.1005434 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Lau MJ, Endersby-Harshman NM, Axford JK, Ritchie SA, Hoffmann AA, Ross PA. Measuring the host-seeking ability of Aedes aegypti destined for field release. Am J Trop Med Hyg. 2020;102(1):223–31. Epub 2019/11/27. doi: 10.4269/ajtmh.19-0510 ; PubMed Central PMCID: PMC6947783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Riegler M, Sidhu M, Miller WJ, O’Neill SL. Evidence for a global Wolbachia replacement in Drosophila melanogaster. Curr Biol. 2005;15(15):1428–33. doi: 10.1016/j.cub.2005.06.069 [DOI] [PubMed] [Google Scholar]
  • 12.Hoffmann AA, Iturbe-Ormaetxe I, Callahan AG, Phillips BL, Billington K, Axford JK, et al. Stability of the wMel Wolbachia infection following invasion into Aedes aegypti populations. PLoS Negl Trop Dis. 2014;8(9):e3115. doi: 10.1371/journal.pntd.0003115 PubMed PMID: WOS:000342796600013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Axford JK, Ross PA, Yeap HL, Callahan AG, Hoffmann AA. Fitness of wAlbB Wolbachia infection in Aedes aegypti: parameter estimates in an outcrossed background and potential for population invasion. Am J Trop Med Hyg. 2016;94(3):507–16. doi: 10.4269/ajtmh.15-0608 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Zhou W, Rousset F, O’Neill S. Phylogeny and PCR–based classification of Wolbachia strains using wsp gene sequences. Proc R Soc Lond B Biol Sci. 1998;265(1395):509–15. doi: 10.1098/rspb.1998.0324 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55(4):611–22. Epub 2009/02/28. doi: 10.1373/clinchem.2008.112797 . [DOI] [PubMed] [Google Scholar]
  • 16.Xi ZY, Khoo CCH, Dobson SL. Wolbachia establishment and invasion in an Aedes aegypti laboratory population. Science. 2005;310(5746):326–8. doi: 10.1126/science.1117607 PubMed PMID: WOS:000232670100056. [DOI] [PubMed] [Google Scholar]
  • 17.Walker T, Johnson PH, Moreira LA, Iturbe-Ormaetxe I, Frentiu FD, McMeniman CJ, et al. The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations. Nature. 2011;476(7361):450–3. doi: 10.1038/nature10355 PubMed PMID: WOS:000294209400036. [DOI] [PubMed] [Google Scholar]
  • 18.Lau MJ, Ross PA, Hoffmann AA. Infertility and fecundity loss of Wolbachia-infected Aedes aegypti hatched from quiescent eggs is expected to alter invasion dynamics. PLoS Negl Trop Dis. 2021;15(2):e0009179. Epub 2021/02/17. doi: 10.1371/journal.pntd.0009179; PubMed Central PMCID: PMC7909672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ross PA, Axford JK, Richardson KM, Endersby-Harshman NM, Hoffmann AA. Maintaining Aedes aegypti mosquitoes infected with Wolbachia. J Vis Exp. 2017;14(126):e56124. doi: 10.3791/56124 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Fredricks DN, Smith C, Meier A. Comparison of six DNA extraction methods for recovery of fungal DNA as assessed by quantitative PCR. J Clin Microbiol. 2005;43(10):5122–8. doi: 10.1128/JCM.43.10.5122-5128.2005 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Demeke T, Ratnayaka I, Phan A. Effects of DNA extraction and purification methods on real-time quantitative PCR analysis of Roundup Ready soybean. J AOAC Int. 2009;92(4):1136–44. Epub 2009/09/01. . [PubMed] [Google Scholar]
  • 22.Ruijter JM, Barnewall RJ, Marsh IB, Szentirmay AN, Quinn JC, van Houdt R, et al. Efficiency correction Is required for accurate quantitative PCR analysis and reporting. Clin Chem. 2021;67(6):829–42. Epub 2021/04/24. doi: 10.1093/clinchem/hvab052 . [DOI] [PubMed] [Google Scholar]
  • 23.Moon K, Lee SH, Kim YH. Validation of quantitative real-time PCR reference genes for the determination of seasonal and labor-specific gene expression profiles in the head of western honey bee, Apis mellifera. PLoS One. 2018;13(7):e0200369. Epub 2018/07/10. doi: 10.1371/journal.pone.0200369; PubMed Central PMCID: PMC6037379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Taylor SC, Nadeau K, Abbasi M, Lachance C, Nguyen M, Fenrich J. The ultimate qPCR experiment: producing publication quality, reproducible data the first time. Trends Biotechnol. 2019;37(7):761–74. Epub 2019/01/19. doi: 10.1016/j.tibtech.2018.12.002 . [DOI] [PubMed] [Google Scholar]
  • 25.Ginzinger DG. Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol. 2002;30(6):503–12. Epub 2002/06/14. doi: 10.1016/s0301-472x(02)00806-8 . [DOI] [PubMed] [Google Scholar]
  • 26.Kontanis EJ, Reed FA. Evaluation of real-time PCR amplification efficiencies to detect PCR inhibitors. J Forensic Sci. 2006;51(4):795–804. Epub 2006/08/03. doi: 10.1111/j.1556-4029.2006.00182.x . [DOI] [PubMed] [Google Scholar]
  • 27.Klappenbach JA, Dunbar JM, Schmidt TM. rRNA operon copy number reflects ecological strategies of bacteria. Appl Environ Microbiol. 2000;66(4):1328–33. doi: 10.1128/AEM.66.4.1328-1333.2000 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Schirrmeister BE, Dalquen DA, Anisimova M, Bagheri HC. Gene copy number variation and its significance in cyanobacterial phylogeny. BMC Microbiol. 2012;12:177. Epub 2012/08/17. doi: 10.1186/1471-2180-12-177; PubMed Central PMCID: PMC3552681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Chrostek E, Teixeira L. Within host selection for faster replicating bacterial symbionts. PloS One. 2018;13(1):e0191530-e. doi: 10.1371/journal.pone.0191530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Chrostek E, Teixeira L. Mutualism breakdown by amplification of Wolbachia genes. PLoS Biol. 2015;13(2):e1002065. doi: 10.1371/journal.pbio.1002065 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Bordenstein SR, Marshall ML, Fry AJ, Kim U, Wernegreen JJ. The tripartite associations between bacteriophage, Wolbachia, and arthropods. PLoS Pathog. 2006;2(5):e43. Epub 2006/05/20. doi: 10.1371/journal.ppat.0020043; PubMed Central PMCID: PMC1463016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Chauvatcharin N, Ahantarig A, Baimai V, Kittayapong P. Bacteriophage WO-B and Wolbachia in natural mosquito hosts: infection incidence, transmission mode and relative density. Mol Ecol. 2006;15(9):2451–61. doi: 10.1111/j.1365-294X.2006.02947.x [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Luciano Andrade Moreira

22 Jul 2021

PONE-D-21-20288

A diagnostic primer pair to distinguish between wMel and wAlbB Wolbachia infection

PLOS ONE

Dear Dr. Lau,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please try to carefully study and respond all the queries raised by both reviewers before you attempt to return your revised manuscript for further revision. There are quite important comments that need to be addressed.

Please submit your revised manuscript by  August 30th. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Luciano Andrade Moreira, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In the manuscript entitled: “A diagnostic primer pair to distinguish between wMel and wAlbB Wolbachia infection”, Lau and colleague’s objective is to improve the real-time PCR diagnostic capabilities of Wolbachia, particularly the wMel and wAlbB strains, currently deployed in field settings around the globe. Based on a gene shared between the two strains (WD_RS06155), and considering the small two-base pair difference between wMel and wAlbB, the authors developed a new primer pair named wMA. Given the data provided, wMA was capable of differentiating between both bacterial strains, while displaying high efficiency and specificity parameters, particularly when compared to commonly primer sets currently employed by the community. I appreciate the concern raised by the authors over the feasibility of this new primer set as a candidate to perform relative measurements of Wolbachia density. Overall, the manuscript is well written, and presented in a clear/easy to understand way. For the most part, experiments are straightforward and well described, with a solid amount of data to support their conclusions. I have listed below, a few suggestions that I believe could improve the quality of the manuscript, prior to acceptance by the editor/Journal.

Comments are displayed in order of appearance:

Line (L) 74: Please provide in this section, more information regarding the gene. If NCBI's designation is correct, the gene is a DNA-directed RNA polymerase subunit beta/beta, with an old locus tag of WD_0024.

L. 84: Small typo right before “[13]”.

L. 88: Please specify here if only females were used for the assays, or if it also included males.

L. 91: Can the authors comment if any other extraction method was used, and if so, how the primers performed on it? For instance, the squash buffer method is commonly employed in certain laboratories as a fast method to detect and quantify Wolbachia.

L. 102: Please indicate the final volume used per reaction mix, as well as the final concentration of each primer used. I also encourage the authors to indicate the degree of transparency of the plasticware used, e.g., white or clear, since different plastics exhibit substantial differences in fluorescence reflection and sensitivity.

L. 107: I encourage the authors to change all designations of “Cp” on the manuscript, to “Cq”. Reasoning for this can be found in the quote below from the widely referenced manuscript for real-time PCR assays: DOI: 10.1373/clinchem.2008.112797

"The nomenclature describing the fractional PCR cycle used for quantification is inconsistent, with threshold cycle (Ct), crossing point(Cp), and take-off point (TOP) currently used in the literature. These terms all refer to the same value from the real-time instrument and were coined by competing manufacturers of real-time instruments for reasons of product differentiation, not scientific accuracy or clarity. We propose the use of quantification cycle (Cq), according to the RDML (Real-Time PCR Data Markup Language) data standard (http:// www.rdml.org)"

L. 112 – Table 1: Please include on this table, the database accession number for each gene of interest, and the amplicon size for each target gene.

L. 122: given the nature of the study in designing a diagnostic primer set, the authors then should include information on how often the assay returns a positive result when a target is present and how often it is negative in the absence of the target. A common requirement of diagnostic assays.

L. 140: This should not be a big issue, given the results here presented, but I encourage the authors to review their lower-end efficiency value of 85% and the citation used to back up their affirmation. Many distinct publications and guidelines for qPCR experiments encourage a range of 90%-110% as acceptable. One example of such literature can be found at DOI: 10.1016/j.tibtech.2018.12.002

L. 156 – Fig. 3: Could each curve be represented using a different color, as to facilitate the reader's visualization of the data?

Reviewer #2: This manuscript describes design and testing of a qPCR primer annealing to D_RS06155 DNA (directed RNA polymerase subunit beta/beta' gene) of Wolbachia. This primer allows to distinguish between wMel and wAlbB in Aedes aegyptii released to control vector-borne diseases. This primer is also compared to other previously published primers.

The primer's name, wMA, resembles designation of a Wolbachia strain (small "w" and Capital letter following). For clarity, shouldn't it be called something else?

This primers Blast perfectly to wMel (but also to wAu, wYak, wTei, wSan). As wAu has also been transinfected to A. aegyptii, this may limit the utility of this primer for field screening of Aedes. Also, sequences annotated as “Wolbachia endosymbiont of Aedes aegyptii” come up in a blast search quite a lot (eg. CP072672.1), which might be confusing, as these Wolbachia likely do not exist (see Ross et al. 2020). If I was designing the primer, I would avoid the possibility of possibly confusing contaminants. The quick homology searches described above seem important for the usage of the primer, but were not performed by authors and included in the text.

Lines 142-146 Shouldn’t samples with contaminants/inhibitors be removed from calibration curves and analysis? How do melting curves for 6x diluted Chelex preps look like?

Lines 160-168 – is it possible that some primer-targeted sequences have multiple copies within the two genomes? Even if they are all 1-copy sequences this is still expected, as Cp will depend on primer sequence/annealing and amplified fragment sequence.

172-173 – Different number of Wolbachia inside mosquito is to be expected, as this is what the qPCR assay is supposed to test for. The differences within Wolbachia genomes are the issue here. Is WD_RS06155 DNA a multi-copy gene in any of the strains? And, in relation to this also lines 174-175 – can you compare the wMel and wAlbB densities using this primer pairs then?

Finally, the figures presented here have very low resolution.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Heverton Leandro Carneiro Dutra

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Sep 23;16(9):e0257781. doi: 10.1371/journal.pone.0257781.r002

Author response to Decision Letter 0


21 Aug 2021

Dear reviewer/editor,

Thank you for giving us the opportunity to submit a revised draft of my manuscript titled “A diagnostic primer pair to distinguish between wMel and wAlbB Wolbachia infections”. We appreciate the time and effort that you and the reviewers have dedicated to providing valuable feedbacks on my manuscript.

We have now addressed all the comments from the two reviewers in the newly uploaded manuscript. We believe our research has significant implications and look forward to hearing from you regarding our submission and to respond to any further questions and comments you may have.

Regards,

Meng-Jia Lau, Ary A. Hoffmann, Nancy M. Endersby-Harshman

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Luciano Andrade Moreira

10 Sep 2021

A diagnostic primer pair to distinguish between wMel and wAlbB Wolbachia infections

PONE-D-21-20288R1

Dear Dr. Lau,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Luciano Andrade Moreira, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #3: In this manuscript the author developed a diagnostic primer pair, wMwA, that can detect and distinguish between the wMel and wAlbB infections in Aedes aegypti. Using Chelex DNA extraction and real-time PCR, the authors provide an easy and economical detecting both currently-released Wolbachia (wMel and wAlbB) infections in Aedes aegypti. As far as the data provided in the manuscript is concerned, the authors provided a robust essay where the primer pair, wMwA, was capable of differentiating between both bacterial strains. In general the experiments are well-controlled and the main conclusions are supported by the data.

Previously the reviewers 1 and 2 presented some suggestions to the manuscript, manly the primers designation and the figures resolution. In my opinion, I observed that the issues raised were addressed in this new version. Concerning the minor comments, the authors fully addressed all points raised by the reviewers.

In conclusion I recommend the publication of the presented review article

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Heverton Leandro Carneiro Dutra

Reviewer #3: Yes: Alvaro Gil Araujo Ferreira

Acceptance letter

Luciano Andrade Moreira

16 Sep 2021

PONE-D-21-20288R1

A diagnostic primer pair to distinguish between wMel and wAlbB Wolbachia infections

Dear Dr. Lau:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Luciano Andrade Moreira

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Real-time PCR reagents and volume in 384-well plates with white wells.

    (DOCX)

    S2 Table. Primer efficiency when sample DNA was first diluted six times.

    (DOCX)

    S3 Table. Primer efficiency when sample DNA was extracted using different methods.

    (DOCX)

    S1 Fig. Primer efficiency when sample DNA was first diluted six times.

    DNA is extracted in 250 μL 5% Chelex® 100 Resin and then diluted six times before making a three-fold dilution series. Outliers are marked with red colour and are excluded from the efficiency curve. The primer names are defined in S3 Table.

    (PNG)

    S2 Fig. Variation in the shape of the PCR amplification curves when sample DNA was first diluted six times.

    The curves from left to right represent amplification curves of 1/6, 1/18, 1/54, 1/162 and 1/486 DNA dilution from 250 μL 5% Chelex® 100 Resin. The primers are defined in S2 Table.

    (PNG)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES